MedPath

Influenza-associated pulmonary aspergillosis (IAPA) in ICU patients with severe influenza: incidence and host- and pathogen related risk factors

Recruiting
Conditions
Influenza-associated pulmonary aspergillosis
pulmonary fungal infection
10017528
Registration Number
NL-OMON55031
Lead Sponsor
Radboud Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
90
Inclusion Criteria

Patients with a PCR-positive respiratory virus panel (RVP) result for influenza
within 96 hours before or 48 hours after ICU admission.
Patients who require ICU admission for more than 24 hours for severe influenza.
Patients who have respiratory distress (respiratory rate >= 25x/minute and
paO2/fiO2 < 300 with or without bilateral infiltrates) as the main reason for
ICU admission.
Patients who do not have an EORTC host factor.
Patients who are at least 18 years of age.

Exclusion Criteria

Patients with age < 18 years as extensive sampling is required
Expected survival on ICU admission <= 48h
Patients that are being treated actively with antifungal agents for invasive
aspergillosis.
Patients or their legal representatives who did not sign the informed consent
form.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath